OPIOIDS. Testing and Interpretation

Similar documents
OPIOIDS. A Comprehensive Look

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Module II Opioids 101 Opiate Opioid

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

Grand Rapids Police Department

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Opioids. Sergio Hernandez, MD

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

Methadone Maintenance

Medication Assisted Treatment. Michael Palladini, RPh MBA CAC

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Given a group of definitions, select the definition of analgesia.

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Opioids Research to Practice

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

3/26/14. Opiates PSY B396 ALCOHOL, ALCOHOLISM, & DRUG ABUSE. Early History Cont d. Early History. Opiate Use in the 19th century. Technology Advances

Analgesics OPIOID ANALGESICS

Pharmacology of Selected Opioid Analgesics

Karam Darwish. Dr. Munir. Munir Gharaibeh

Opioids and Heroin in Snohomish County. Marijuana and Opioid Prevention Training May 2018

People inject, sniff, snort, or smoke heroin. Some people mix heroin with crack cocaine, a practice called speedballing.

3/15/2018. Pain. Pain. Opioid Analgesics Addiction. Pain

Pharmacology of Selected Opioid Analgesics

Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China

Buprenorphine pharmacology

Prescription Opioid Addiction

Opioids Research to Practice

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Opioids Research to Practice

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Dr. Hiwa K. Saaed. PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Analgesic

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

Opioids. October 29, Addiction Medicine Review Course CSAM, Newport Beach, CA

Prescription Opioids

Urine Drug Testing Methods 3-5

Treating Opioid Use Disorders: An Update for Counselors and Other Providers

HIV/AIDS Definition: CDC Classification of HIV Infection Stage 1: Stage 2: Stage 3: Risk Factors

8/28/2017. Headlines. How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room.

Vermont's Opioid Crisis and Response to the Crisis

Responding to the Opioid Addiction Epidemic

OPIATES AND ADDICTION MEDICATIONS. Dr. Carroll W. Thornburg, D.O Chief Medical Officer in Primary Care and Addiction Services

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

Session 7: Opioids and Club Drugs 7-1

Heroin What You Need to Know

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Lethal doses of oxycodone

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue

Morphine Sulfate Hydromorphone Oxymorphone

Urine drug testing it s not always crystal clear

Preventing Opioid Misuse and Use: The Lucky Preventionist s Guide to Strategic Planning

3/16/2018. Responding to a crisis. Opioid Overdose Prevention

disease or in clients who consume alcohol on a regular basis. bilirubin

How much codeine is in oxycontin

Opiates: Use, Abuse, and Detection

Allergic to hydrocodone can i take tramadol

Opioids Research to Practice

Opioid Toxicity - Objectives. Opioid Toxicity: A Poison Center. and Pediatric Perspective. Greatest Increase is Exposures

30 mg codeine vs 5 mg hydrocodone

Testing for Controlled Substances

Heroin. Brain Research Institute, UCLA Alison Taylor

Top 10 narcotic pain pills

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans

Opioid Use in Youth. Amy Yule M.D. March 2,

A prisoners guide to buprenorphine

Opioid Pain Medications Frequently Asked Questions

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services

Substances under Surveillance

Can a shot of morphine show positive for oxycodone

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Heroin, Fentanyl and Other Opioids. Steve Hanson

Pain Medication Management Program Supports Patient Outcomes and Adherence

Chris Herndon, PharmD, FCCP Professor, School of Pharmacy

Drug Screening: Things You Need to Know

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

Fentanyl Fact and Fiction: The Rise of America s Narcotic Crisis. Dan

High Risk Medications. University of Illinois at Chicago College of Nursing

Implementing Buprenorphine Treatment in Opioid Treatment Programs Webinar 2, October 3, 2018

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Heroin. What is heroin?

Urine Testing for Opioids

Overview of Opioid Use Disorder

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Naloxone Standing Order for Opioid Overdose

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

Dr Alistair Dunn. General Practitioner Whangarei

OPIOID REPLACEMANT THERAPY: AN OVERVIEW

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

Transcription:

OPIOIDS Testing and Interpretation

TOPICS OF DISCUSSION Effects of Opioids Opiates vs. Opioids Drug Testing Recent Trends OPIOIDS: Testing and Interpretation 2018 2

EFFECTS OF OPIOIDS 3

Opioid Receptors µ (mu) receptor: produce central depression analgesia, respiratory depression, miosis, euphoria, reduced gastrointestinal motility, hypothermia, bradycardia, physical tolerance and dependence Κ (kappa) receptor: produce spinal analgesia, sedation, miosis, diuresis, mild respiratory depression and low addiction liability δ (delta) receptor: spinal analgesia, dysphoria, delusions, hallucinations, and respiratory and vasomotor stimulation OPIODS: Testing and Interpretation 2018 4

AGONIST AND ANTAGONIST Opioids are classified into three groups Full agonist : compounds that have an affinity for opioid receptors of a certain type Mixed agonist-antagonist: compounds with an agonistic effect at one class of receptor and an antagonistic effect at another Full antagonist: compounds that inhibit agonist binding of other compounds; have reduced analgesic effect and are primarily used for the treatment of opioid intoxication 5

EFFECTS Nervous Euphoria Analgesia Sedation Mental clouding and mood swings Pulmonary Respiratory Depression Decreased Responsiveness Gastrointestinal Nausea Vomiting Constipation Other Cough suppression Miosis Truncal rigidity Flushing and warming of the skin Sweating and itching OPIOIDS: Testing and Interpretation 2018 6

EFFECTS Human Performance Driving Slow driving Weaving Poor vehicle control Poor coordination Slow response to stimuli Delayed reactions Difficulty following instructions Falling asleep at the wheel OPIOIDS: Testing and Interpretation 2018 7

WARNING www.drugrehab.com 8

OPIATES VS. OPIOIDS Classification 9

DEFINITIONS Opiates alkaloids derived directly from the poppy plant Opioids broader class of drugs that are capable of either producing opium like effects or binding to opioid receptors Semisynthetic opioids created by the chemical modification of an opiate Synthetic opioids a chemical compounds not derived from an opiate, that are capable of binding to an opioid receptor and producing opioid effects clinically 10

OPIATES ALKALOIDS DERIVED DIRECTLY FROM THE POPPY PLANT Opium Morphine, Codeine, Thebaine, Papaverine, Noscapine, Oripavine Morphine Extracted from opium, 1806 Named after Morpheus, the god of dreams Strong µ agonist, weak δ and κ agonist Analgesic Potency = 1 Anesthetic supplement, injuries, musculoskeletal, pain management Schedule II/III 11

OPIATES ALKALOIDS DERIVED DIRECTLY FROM THE POPPY PLANT Codeine Extracted from opium, also derived from methylation of morphine Weak µ agonist, weak δ agonist Analgesic Potency = 0.1 Injuries, musculoskeletal, cough Schedule II/III Analgesic Potency 1.2 1 0.8 0.6 0.4 0.2 Analgesic Potency of Opiates/Opioids 0 Morphine Codeine 12

SEMISYNTHETIC OPIOIDS Hydrocodone Derived from Codeine µ agonist Analgesic Potency = 1-2 Injuries, musculoskeletal, pain management, cough Schedule II Hydromorphone Derived from Morphine Strong µ agonist Analgesic Potency = 7-10 Injuries, musculoskeletal, pain management Schedule II Analgesic Potency 9 8 7 6 5 4 3 2 1 0 Analgesic Potency of Opiates/Opioids 13

SEMISYNTHETIC OPIOIDS Oxycodone Derived from Thebaine µ agonist Analgesic Potency = 1-2 Injuries, musculoskeletal, pain management Schedule II Oxymorphone Derived from Thebaine Strong µ agonist Analgesic Potency = 8-15 Injuries, musculoskeletal, pain management Schedule II Analgesic Potency 12 10 8 6 4 2 0 Analgesic Potency of Opiates/Opioids 14

SEMISYNTHETIC OPIOIDS Heroin Derived from Morphine, 1874 Sold as a pharmaceutical until abuse became rampant Strong µ agonist Analgesic Potency = 4-5 6-AM metabolite is 4 times more potent than morphine Schedule I https://www.deamuseum.org/ccp/opium/history.html 15

SEMISYNTHETIC OPIOIDS Buprenorphine Derived from Thebaine Parital µ agonist, κ agonist High affinity to receptors producing longer-lasting morphine-like analgesia Analgesic Potency = 40 Detoxification and maintenance in heroin dependence, pain management Schedule III https://www.confirmbiosciences.com/knowledge/drug-facts/buprenorphine/ 16

ABSTINENCE SYNDROME 8-12 hours Watery eyes Yawning Mucus fills nasal cavity Perspiration 12-24 hours Irritability Goose flesh Restless sleep Weakness Pupil dilation Tremors Loss of appetite Muscle twitching 17

ABSTINENCE SYNDROME 48-72 hours Increased irritability Increased heart rate Insomnia Hypertension Loss of Appetite Hot and cold flashes Sneezing Alternating sweating and flushing Nausea and vomiting Piloerection Body temperature increases Rapid breathing Abdominal cramps Aching muscles Syndrome duration 7-10 days 18

SEMISYNTHETIC OPIOIDS Naloxone Derived from Oxymorphone Strong µ antagonist Reverse the effects of opioids, overdose treatment Not scheduled Naltrexone Derived from Oxymorphone Strong µ antagonist Reverse the effects of opioids, overdose treatment Not scheduled www.narcan.com 19

ANTAGONIST Stronger affinity to the opioid receptors Lasts for 30-90 minutes Allowing person to breathe again and reverse overdose https://www.northcarolinahealthnews.org/2017/07/12/naloxone-101-works-using/ 20

SYNTHETIC OPIOIDS Fentanyl Strong µ agonist Analgesic Potency = 100-200 Pre-/postoperative, anesthetic supplement, pain management Schedule II Methadone Strong µ agonist Analgesic Potency = 1 Detoxification, maintenance, pain management Schedule II Meperidine Strong µ agonist Analgesic Potency = 0.1 Injuries, postoperative pain, obstetrics Schedule II Propoxyphene µ agonist Analgesic Potency = <0.1 Schedule IV No longer sold in US, 2011 21

SYNTHETIC OPIOIDS Tramadol µ agonist Analgesic Potency = 0.1-0.2 Injuries, musculoskeletal, pain management Schedule IV Others Diphenoxylate treat diarrhea LAAM (levacetylmethadol) treat opiate addiction Loperamide treat diarrhea Tapentadol treat moderate to severe pain 22

DRUG TESTING OPIATES and OPIOIDS OPIOIDS: Testing and Interpretation 2018 23

PREFERRED MATRICES 24

URINE Detection time is 24-72 hours Pros Ability to split the sample for additional testing Industry standard Broad cost effective menu Cons Requires visually observed collection to avoid adulteration/substitution Potential for specimen dilution/adulteration in vivo and in vitro OPIOIDS: Testing and Interpretation 2018 25

ORAL FLUID Detection time is 12-36 hours Pros Samples may be collected in the field and does not require same gender collection. If collected correctly, it is difficult to adulterate Is recommended for clients that may be on certain medications or for medical reasons (Dialysis/catheter) Cons Short detection period Ineffective for THC Detection Moderate cost OPIOIDS: Testing and Interpretation 2018 26

HAIR FOLLICLE Detection time for head hair: 14-90 days prior Detection time for body hair: 30-365 days prior Pros Effective baseline test Unknown drug use history Adulteration difficult Cons Not useful for routine monitoring Limited test menu Head hair may not be available May not pick up a single drug use OPIOIDS: Testing and Interpretation 2018 27

DETECTION PERIODS Media Urine Oral Fluid Hair Approximate Detection Period 24-72 hours 12-36 hours Head hair: 14-90 days prior Body hair: 30-365 days prior OPIOIDS: Testing and Interpretation 2018 28

INITIAL SCREENING TESTS Immunoassay Point of Care Testing (POCT) Lab Based Fast Minimal sample prep False positives 29

OPIATES/OPIOIDS IN URINE Looking for: Codeine/Morphine/Hydrocodone/ Hydromorphone Oxycodone/Oxymorphone Heroin Methadone Buprenorphine Fentanyl Test for: Opiates Oxycodone Heroin (in conjunction with Opiate test) Methadone Buprenorphine Fentanyl 30

CONFIRMATION TESTING GC/MS LC/MS/MS Positive identification Quantitation Sample preparation required www.agilent.com 31

GC/MS RESULTS Morphine Codeine Oxymorphone Hydromorphone 6-MAM Oxycodone Hydrocodone 32

GCMS INTERPRETATION Drug Opiate Parent Drug/Metabolite Heroin Diacetylmorphine 6-MAM, Morphine, Codeine Tylenol #3, #4 Codeine Codeine, Morphine MS Contin, Roxanol Morphine Morphine, Hydromorphone Vicodin, Vicoprofen, Tussionex, H-C Tussive Hydrocodone Hydrocodone, Hydromorphone Dilaudid Hydromorphone Hydromorphone Oxycontin, Percodan, Percoset, Roxicet Oxycodone Oxycodone, Oxymorphone Opana Oxymorphone Oxymorphone OPIOIDS: Testing and Interpretation 2018 33

CASE #1 34

CASE #2 35

CASE #3 36

CASE #4 GCMS 6-MAM Negative 10 NG/ML GCMS URINE 37

EXAMINING THE EXCUSES - OPIATES I am positive for opiates because of my methadone. Synthetic Opioids will not test positive on the standard opiate screening test. Methadone Buprenorphine Tramadol Fentanyl Meperidine I tested positive because I ate a poppy seed bagel. Possible morphine in or on the seeds Problematic at the 300 ng/ml cutoff OPIOIDS: Testing and Interpretation 2018 38

CUTOFF LEVELS/COMPARING RESULTS Regulated standards observed by SAMHSA, CLIA, CAP Set to eliminate positive results due to incidental exposure Reports will indicate cutoff levels for screening and confirmation testing Results from different samples collected the same day may not correlate. Hair vs. Urine Oral Fluid vs. Urine OPIOIDS: Testing and Interpretation 2018 39

RECENT TRENDS OPIOIDS: Testing and Interpretation 2018 40

Embedded PowerPoint Video 42

LOPERAMIDE Imodium µ agonist in the myenteric plexus of the large intestine Excessive dosing (10+ times higher than recommended) At high concentrations loperamide can cross the blood-brain barrier Attempt to get high Treat opioid withdrawal symptoms Can fatally disrupt the heart s rhythm Insufflation may be attempted 42

FENTANYL Uses Pain 50-100 times more potent than morphine Actiq, Duragesic, Sublimaze Abuse Street names: China Girl, China White, Tango and Cash Patches Remove the gel and take the entire 3-day dose at one time Wear multiple patches 43

DEADLY SYNTHETIC OPIOIDS U-47700 PINK 8 times more potent than morphine Sold as a research chemical (China) No approved medical use Not approved for human consumption FDA DEA Schedule I ban November 2016 46 confirmed fatalities between October 2015-September 2016 Image from www.nydailynews.com 44

DEADLY SYNTHETIC OPIOIDS Non-Pharmaceutical Fentanyl Carfentanil (Wildnil) Schedule II 10,000 times more potent than morphine Intended for large-animal use DEA Issues public warning in September 2016 2 mg could be lethal Powder, blotter paper, tablets, spray Can be absorbed through skin or inhaled 45

DEADLY SYNTHETIC OPIOIDS Sufentanil 500-1000 times more potent than morphine Furanyl Fentanil 20 times more potent than morphine Acetylfentanyl 15 times more potent than morphine Many others with varying degrees of potency 46

KRATOM Mitragynine Extract from tropical tree Mitragyna speciosa, native to Southeast Asia Currently not scheduled At low doses produces stimulant effect Increased energy, sociability, alertness At high doses produces opioid effect Sedation, pleasure, decreased pain Image from www.kratomspot.com 47

THANK YOU